Tools created in Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders aid rapid screening of compound libraries for chemicals targeting oligomeric stage of fibrillization.

Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders Lab showed that small aggregates of alpha-synuclein ...